Brief: Alpine Immune Sciences Q3 EPS USD -0.24
14/11/2023 21:15
Nov 14 (Reuters) - Alpine Immune Sciences Q3 collaboration revenue USD 10.043 million. * Q3 operating expenses USD 24.593 million * Q3 income from operations USD -14.55 million * Q3 net income USD -11.722 million
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings